Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 2020Diabetes TherapyOpen Access

Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

ZZZhiwei ZengSHShiying HuangTSTao Sun

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeng et al. (2020) studied this question.

synapsesocial.com/papers/6a1b77fb950e49a3ca0c694ehttps://doi.org/10.1007/s13300-020-00922-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes2010 · 77 citations
  2. 2The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin2009 · 347 citations
  3. 3Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients2018 · 25 citations
  4. 4<scp><i>KCNQ1</i></scp> gene polymorphisms are associated with the therapeutic efficacy of repaglinide in <scp>C</scp>hinese <scp>T</scp>ype 2 diabetic patients2012 · 38 citations
  5. 5Single Nucleotide Polymorphisms of the Peroxisome Proliferator–Activated Receptor-α Gene (PPARA) Influence the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes2007 · 61 citations